Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

octreotide pamoate

A synthetic long-acting octapeptide analogue of endogenous somatostatin. Octreotide pamoate binds to somatostatin receptors expressed by some neuroendocrine and non-neuroendocrine tumor cells, thereby initiating somatostatin receptor-mediated apoptosis. Other possible antineoplastic activities of this agent include suppression of tumor angiogenesis and tumor growth-promoting insulin-like growth factor 1 (IGF-1).
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:octreotide pamoate LAR(SMS 201-995)
OP LAR
US brand name:OncoLAR
Sandostatin pamoate
Sandostatin pamoate LAR
Code name:SMS 201-995 pa
SMS 201-995 pa LAR
IND number:52010
NSC code:685403
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search